Fluordeoxyglucose FDG

Description

In cancer cells the (¹⁸F) FDG is transported via the plasma membrane in a similar way as glucose molecules, but it cannot be incorporated into the glycolytic cycle since it does not pass the (¹⁸F) fluordeoxyglucose-6-phosphate and is consequently retained in the tumor. Diagnostic indications:
For studies with Positron Emission Tomography (PET), in tumors or lesions with increased metabolic activity of the adenocarcinoma type, tumors of epithelial origin, sarcomas, Hodgkin's lymphoma, Non-Hodgkin's lymphoma, diffuse B-cell and follicular lymphoma, solitary lung nodule, metastasis of cervical adenopathies of unknown origin, primary lung cancer, colorectal cancer, lymphomas, lymphomas, Diffuse B-cell and Follicular, solitary lung nodule, metastasis of cervical adenopathies of unknown origin, primary lung cancer, colorectal cancer, malignant lymphomas and melanomas, studies of cardiomyopathies, etc.

Category: BIOMARKER

Sub - Category: Diagnostic product for “in vivo” use”

Technical Data